Since CD44 knockdown was found to suppress HCT116‐CSCs migration and invasion in vitro, xenograft tumor growth assay was performed to examine the effects of CD44 knockdown on in vivo tumorigenicity and metastasis in nude mice. This evidence concerns the gene CD44 and neoplasm.